• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服纳曲酮后的生物等效性、剂量比例性及药代动力学

Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.

作者信息

Meyer M C, Straughn A B, Lo M W, Schary W L, Whitney C C

出版信息

J Clin Psychiatry. 1984 Sep;45(9 Pt 2):15-9.

PMID:6469932
Abstract

Healthy male volunteers (N = 24) participated in a four-way crossover study to compare the rate and extent of absorption of naltrexone after administration of 50 mg tablets as 50, 100, and 200 mg doses and a 10 mg/ml reference syrup. A high-performance liquid chromatographic method was employed to measure naltrexone and 6-beta-naltrexol in plasma and urine. Compared to the syrup, the 50 mg tablets were absorbed more slowly but equally well. There was excellent linearity between the administered dose and the area under the plasma concentration-time profile, as well as total urinary recovery of both drug and metabolite. The mean half-lives for naltrexone and beta-naltrexol were approximately 4 and 12 hours, respectively. The fraction of drug reaching the systemic circulation was estimated to be 5% of the administered dose because of extensive first-pass metabolism. Less than 1% of the dose was excreted in the urine as naltrexone after 48 hours, while 25% was recovered as unconjugated beta-naltrexol. The renal clearance of naltrexone and beta-naltrexol was approximately 127 ml/min and 283 ml/min, respectively. The total systemic clearance for naltrexone was approximately 94 L/hr.

摘要

健康男性志愿者(N = 24)参与了一项四交叉研究,以比较服用50毫克片剂(剂量分别为50、100和200毫克)和10毫克/毫升参比糖浆后纳曲酮的吸收速率和吸收程度。采用高效液相色谱法测定血浆和尿液中的纳曲酮和6-β-纳曲醇。与糖浆相比,50毫克片剂吸收较慢,但吸收程度相同。给药剂量与血浆浓度-时间曲线下面积以及药物和代谢物的总尿回收率之间具有良好的线性关系。纳曲酮和β-纳曲醇的平均半衰期分别约为4小时和12小时。由于广泛的首过代谢,进入体循环的药物分数估计为给药剂量的5%。48小时后,作为纳曲酮经尿液排泄的剂量不到1%,而作为未结合β-纳曲醇回收的剂量为25%。纳曲酮和β-纳曲醇的肾清除率分别约为127毫升/分钟和283毫升/分钟。纳曲酮的总全身清除率约为94升/小时。

相似文献

1
Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.口服纳曲酮后的生物等效性、剂量比例性及药代动力学
J Clin Psychiatry. 1984 Sep;45(9 Pt 2):15-9.
2
Naltrexone disposition in man after subcutaneous administration.皮下注射后纳曲酮在人体内的处置情况。
Drug Metab Dispos. 1984 Nov-Dec;12(6):677-82.
3
Metabolism and disposition of naltrexone in man after oral and intravenous administration.
Drug Metab Dispos. 1981 Jul-Aug;9(4):369-75.
4
Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.长效注射用纳曲酮的单剂量和多剂量药代动力学
Alcohol Clin Exp Res. 2006 Mar;30(3):480-90. doi: 10.1111/j.1530-0277.2006.00052.x.
5
The urinary excretion profiles of naltrexone in man, monkey, rabbit, and rat.
Drug Metab Dispos. 1976 Sep-Oct;4(5):474-8.
6
Overview of human pharmacokinetics of naltrexone.纳曲酮的人体药代动力学概述。
NIDA Res Monogr. 1981;28:161-71.
7
The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit.纳曲酮在兔体内的精液排泄、血浆消除、组织分布及代谢
J Pharmacol Exp Ther. 1980 May;213(2):289-99.
8
Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys.
Drug Metab Dispos. 1989 Nov-Dec;17(6):583-9.
9
Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.芬太尼泡腾颊片(FEBT)1080微克与口腔黏膜枸橼酸芬太尼1600微克的相对生物利用度以及FEBT 270至1300微克的剂量比例:一项在健康成年志愿者中进行的单剂量、随机、开放标签、三周期研究。
Clin Ther. 2006 May;28(5):715-24. doi: 10.1016/j.clinthera.2006.05.016.
10
Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.纳曲酮的代谢还原。I. 纳洛酮和纳曲酮还原产物的合成、分离与表征以及在给予纳曲酮、α-纳曲醇或β-纳曲醇后尿液和胆汁的定性分析。
Res Commun Chem Pathol Pharmacol. 1975 Sep;12(1):43-65.

引用本文的文献

1
Nalmefene Hydrochloride: Potential Implications for Treating Alcohol and Opioid Use Disorder.盐酸纳美芬:对治疗酒精和阿片类物质使用障碍的潜在意义。
Subst Abuse Rehabil. 2024 Apr 3;15:43-57. doi: 10.2147/SAR.S431270. eCollection 2024.
2
Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy.低剂量纳曲酮作为联合抗癌治疗的辅助药物
Cancers (Basel). 2024 Mar 21;16(6):1240. doi: 10.3390/cancers16061240.
3
Effects of dopamine and opioid receptor antagonism on the neural processing of social and nonsocial rewards.多巴胺和阿片受体拮抗作用对社会和非社会奖励的神经加工的影响。
Hum Brain Mapp. 2024 Mar;45(4):e26645. doi: 10.1002/hbm.26645.
4
Effects of genotype and food on naltrexone exposure in adolescents.基因型和食物对青少年纳曲酮暴露的影响。
Clin Transl Sci. 2022 Nov;15(11):2732-2743. doi: 10.1111/cts.13399. Epub 2022 Oct 5.
5
Stress-induced analgesia: an evaluation of effects on temporal summation of pain and the role of endogenous opioid mechanisms.应激诱导的镇痛:对疼痛时间总和的影响及内源性阿片机制作用的评估。
Pain Rep. 2022 Feb 8;7(2):e987. doi: 10.1097/PR9.0000000000000987. eCollection 2022 Mar-Apr.
6
The Impact of Age and Genetics on Naltrexone Biotransformation.年龄和遗传因素对纳曲酮生物转化的影响。
Drug Metab Dispos. 2022 Feb;50(2):168-173. doi: 10.1124/dmd.121.000646. Epub 2021 Nov 2.
7
Developmental Considerations for the Use of Naltrexone in Children and Adolescents.纳曲酮在儿童和青少年中使用的发育方面考量
J Pediatr Pharmacol Ther. 2021;26(7):675-695. doi: 10.5863/1551-6776-26.7.675. Epub 2021 Sep 24.
8
Probing the Release of Bupropion and Naltrexone Hydrochloride Salts from Biopolymeric Matrices of Diverse Chemical Structures.探究盐酸安非他酮和盐酸纳曲酮从不同化学结构的生物聚合物基质中的释放情况。
Polymers (Basel). 2021 Apr 30;13(9):1456. doi: 10.3390/polym13091456.
9
Mobile alcohol biosensors and pharmacotherapy development research.移动酒精生物传感器和药物治疗开发研究。
Alcohol. 2019 Dec;81:149-160. doi: 10.1016/j.alcohol.2018.07.012. Epub 2018 Aug 3.
10
Treating gambling disorder with as needed administration of intranasal naloxone: a pilot study to evaluate acceptability, feasibility and outcomes.按需经鼻给予纳洛酮治疗赌博障碍:一项评估可接受性、可行性和结局的初步研究。
BMJ Open. 2019 Aug 21;9(8):e023728. doi: 10.1136/bmjopen-2018-023728.